Role of radiotherapy in the management of heterotopic ossification

Heterotopic ossification (HO) is a process of pathological bone formation in non-osseous tissue. Frequently, it complication that occurs from various causes such as traumatic, neurogenic, or genetic disorders, where trauma the most common cause. HO major concern can lead to functional pain, and even joint ankylosis. Non-steroidal anti-inflammatory drugs radiotherapy (RT) are preferred treatment HO. RT serves an important modality for management because potentially inhibits osteoprogenitor cell proliferation. This case report 18-year-old girl, who developed grade 4 at her right hip following fall height. She, then, underwent excision heterotopic dose 8 gray (Gy) delivered 1 fraction, within 48 h excision. The patient did not any acute adverse effects related demonstrated clinical improvement range motion without recurrence 3 6-month follow-ups.